Abstract The Alzheimer's Disease Neuroimaging Initiative (ADNI) is an ongoing,
longitudinal, multicenter study designed to develop clinical, imaging, genetic, and …

The Alzheimer's Disease Neuroimaging Initiative (ADNI) beginning in October 2004, is a 6-
year research project that studies changes of cognition, function, brain structure and …

Abstract The Alzheimer's Disease Neuroimaging Initiative (ADNI) is an ongoing,
longitudinal, multicenter study designed to develop clinical, imaging, genetic, and …

Decline in executive function has been noted in the prodromal stage of Alzheimer's disease
(AD) and may presage more global cognitive declines. In this prospective longitudinal study …

Background The three core pathologies of Alzheimer's disease (AD) are amyloid pathology,
tau pathology, and neurodegeneration. Biomarkers exist for each. Neurodegeneration is …

There is increasing consensus regarding the importance of operationally defining and
measuring functional decline in mild cognitive impairment (MCI). However, few studies have …

Using cluster analysis Libon et al.(2010) found three verbal serial list-learning profiles
involving delay memory test performance in patients with mild cognitive impairment (MCI) …

Background Decline in episodic memory is one of the hallmark features of Alzheimer's
disease (AD) and is also a defining feature of amnestic Mild Cognitive Impairment (MCI) …

Objective: To evaluate whether ratings on Clinical Dementia Rating (CDR) items related to
instrumental activities of daily living (IADL) are associated with cognitive or brain …

Mild cognitive impairment (MCI) and Alzheimer's disease (AD) are associated with a
progressive loss of cognitive abilities. In the present report, we assessed the relationship of …